TCTC Holdings’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-800
Closed -$71.9K 605
2025
Q4
$71.9K Hold
800
﹤0.01% 307
2025
Q3
$78.8K Sell
800
-48
-6% -$4.76K ﹤0.01% 290
2025
Q2
$77.3K Sell
848
-44
-5% -$4.25K ﹤0.01% 293
2025
Q1
$101K Buy
892
+8
+0.9% +$856 ﹤0.01% 256
2024
Q4
$93.4K Buy
884
+40
+5% +$4.29K ﹤0.01% 260
2024
Q3
$91.1K Sell
844
-90
-10% -$9.82K ﹤0.01% 264
2024
Q2
$101K Hold
934
﹤0.01% 257
2024
Q1
$123K Hold
934
﹤0.01% 233
2023
Q4
$114K Hold
934
﹤0.01% 235
2023
Q3
$105K Hold
934
﹤0.01% 223
2023
Q2
$136K Hold
934
0.01% 211
2023
Q1
$121K Buy
934
+134
+17% +$16.8K ﹤0.01% 222
2022
Q4
$102K Hold
800
﹤0.01% 223
2022
Q3
$84K Hold
800
﹤0.01% 225
2022
Q2
$84K Hold
800
﹤0.01% 234
2022
Q1
$102K Sell
800
-24
-3% -$2.89K ﹤0.01% 232
2021
Q4
$102K Hold
824
﹤0.01% 257
2021
Q3
$117K Hold
824
0.01% 236
2021
Q2
$129K Hold
824
0.01% 207
2021
Q1
$128K Hold
824
0.01% 201
2020
Q4
$123K Hold
824
0.01% 196
2020
Q3
$109K Hold
824
0.01% 196
2020
Q2
$95K Buy
+824
New +$95K 0.01% 201

Other funds holding ZBH

TCTC Holdings's ZBH Position: Q1 2026 in Review

TCTC Holdings sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 800 shares — an estimated $71.9K sold.

TCTC Holdings first reported a position in ZBH in Q2 2020 and held it in 23 quarters. The position peaked at $136K in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • TCTC Holdings reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • TCTC Holdings sold 800 Zimmer Biomet shares in Q1 2026, an estimated $71.9K.
  • TCTC Holdings first reported a position in Zimmer Biomet in Q2 2020 and held it in 23 quarters.
  • TCTC Holdings's Zimmer Biomet position peaked at $136K in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on TCTC Holdings's 13F filing for Q1 2026, filed 7 May 2026.